工程化间充质干细胞调控综合应激反应以实现纤维化治疗目标
Engineered mesenchymal stem cells regulate integrated stress response for fibrosis therapy
Jie Yu, Shuhua Yin, Jiong Li, Yilin Zhang, Xiuli Zhong, Nuo Zhou, Wei Li, Yixin Wang, Renke Li, Minjie Sun, Zhaoting Li
Journal:Med
IF:13.3
DOI:10.1016/j.medj.2026.101261
PMID:42586072
Published:2026-08-12
research field:呼吸生物学进化生物学微生物学食品科学植物病理学生物技术
Abstract
Background Pulmonary fibrosis is a fatal disease with limited therapeutic options. Aberrant activation of the integrated stress response (ISR) disrupts proteostasis and promotes fibrogenesis, yet effective strategies for targeted ISR regulation in fibrotic diseases remain insufficiently explored. Methods Here, we engineered mesenchymal stem cells (MSCs) as living carriers for targeted co-delivery of ISRIB and nicotinamide mononucleotide (NMN). ISRIB- and NMN-loaded liposomes were conjugated onto MSCs through cleavable linkers (M-Lip@IN), enabling MSC-mediated homing and microenvironment-responsive cargo release in fibrotic lesions. Findings M-Lip@IN effectively accumulated in fibrotic lungs and promoted local liposome release. ISRIB directly regulated pathological ISR activation, whereas NMN supported NAD(H)-SIRT1-related metabolic homeostasis, collectively enabling coordinated regulation of epithelial stress responses. Augmented by MSC-mediated biological support, M-Lip@IN reduced collagen deposition, inhibited profibrotic signaling, improved epithelial cell composition, promoted lung repair, and ameliorated bleomycin-induced pulmonary fibrosis, with additional antifibrotic effects observed in carbon-tetrachloride-induced liver fibrosis. Conclusions Our study presents an engineered MSC-based platform that integrates lesion targeting, responsive drug release, and coordinated regulation of epithelial stress responses. By combining ISR modulation with metabolic resilience, M-Lip@IN restores stress homeostasis, improves epithelial cell composition, and promotes lung repair. These findings support targeted ISR regulation as a potential therapeutic strategy for pulmonary fibrosis and other fibrotic diseases. Funding This work was supported by the Shenzhen Science and Technology Program, the Guangdong Basic and Applied Basic Research Foundation, the National Natural Science Foundation of China, the University Development Research Start-up Fund, and the Pengcheng Peacock
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


